SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026555
Filing Date
2021-05-11
Accepted
2021-05-11 16:16:05
Documents
90
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q beam-10q_20210331.htm   iXBRL 10-Q 2335937
2 EX-31.1 beam-ex311_9.htm EX-31.1 18464
3 EX-31.2 beam-ex312_6.htm EX-31.2 18742
4 EX-32.1 beam-ex321_8.htm EX-32.1 8527
5 EX-32.2 beam-ex322_7.htm EX-32.2 7941
  Complete submission text file 0001564590-21-026555.txt   10151760

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA beam-20210331.xsd EX-101.SCH 75351
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE beam-20210331_cal.xml EX-101.CAL 61944
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE beam-20210331_def.xml EX-101.DEF 285614
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE beam-20210331_lab.xml EX-101.LAB 519560
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE beam-20210331_pre.xml EX-101.PRE 475213
11 EXTRACTED XBRL INSTANCE DOCUMENT beam-10q_20210331_htm.xml XML 2123600
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39208 | Film No.: 21911510
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences